Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae

Summary

Determine safety and feasibility of using institutionally prepared autologous, uncultured SVF on patients with aerodigestive and enterocutaneous fistulae secondary to malignancy, trauma or surgery.

Timeline

Start

2021-02

Primary completion

2027-02

Completion

2028-02

Outcome

Outcome not reported

Stopped (Enrollment): “Study closed due to lack of patient enrollment.”

Drugs

Indications